Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.
Please read the tutorial at this link: https://ebookbell.com/faq
We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.
For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.
EbookBell Team
4.0
86 reviewsProviding an important and timely overview of research in the field of entrepreneurship in biotechnology, The Handbook of Bioentrepreneurship examines one of the most promising industries of the 21st century. While genetically engineered foods and biopharmaceuticals have made biotechnology part of our everyday lives, launching a bioventure is among the most complex and risky entrepreneurial undertakings, given long development cycles, high levels of technological and market uncertainty, and extraordinary capital requirements. Featuring unparalleled, in-depth analysis from experts around the world, the Handbook sheds light on emerging business models and strategies, geographical and regional networks, cooperation between firms and universities, legal frameworks, and policy issues that influence the context in which biotech ventures are established and the conditions under which they may flourish. Reviewing and showcasing state-of-the-art data, examples, theoretical insights, and practical applications, the Handbook will serve as an essential resource for researchers and students in entrepreneurship, corporate strategy, technology management, and economic policy, as well as business leaders, investors, scientists, and policymakers with a stake in the dynamic, high-growth industry of biotechnology.